Top Section/Ad
Top Section/Ad
Most recent
A handful of large new listings have emerged from South Africa, Kenya and Angola and more are set to follow
Submarine mast maker's IPO raised €132.8m
Vincorion is expected to continue defence IPOs later this week
More articles/Ad
More articles/Ad
More articles
-
Chinese infant milk formula maker Feihe has raised HK$6.7bn ($856m) from its Hong Kong IPO. Investors put in enough orders to cover the deal by multiple times at the bottom of guidance. -
Saudi Arabia is gathering feedback on how investors see the value of its unique oil company, Aramco, through an army of investment banks. It will have to choose between two priorities: pushing for the crown prince's cherished $2tr valuation or the potentially bigger prize of attracting a wide range of international investors, writes Sam Kerr.
-
EMEA equity capital markets houses are finding a receptive audience for accelerated share sales as stockmarket indices hit new highs. But despite this, IPOs still face difficulties.
-
YX Asset Recovery, a Chinese consumer debt restructuring specialist, has started gauging investor appetite for an IPO of around $200m on the The New York Stock Exchange.
-
Biopharmaceutical firm SinoMab BioScience has priced its Hong Kong listing at the bottom of guidance to raise HK$1.4bn ($178.6m), finding support from global long-only funds on the last day of bookbuilding.
-
The launch of Saudi Aramco’s IPO on Sunday will begin a fortnight of feverish debates and valuation discussions among investors and banks. But Aramco is not just an investment in an oil company: it is an invitation to be a junior investor in the state of Saudi Arabia — with all the dangers and upside that entails.
